Near-total relief ‘ambitious but achievable’: New advice raises the bar for migraine treatment success
Neurologists says new drugs offer the prospect of complete relief for some patients.
Actual days per month with migraine symptoms is a better target for treatment success than the long-accepted standard of a 50% reduction in migraine days, a new position statement says.
The International Headache Society (IHS) has declared that treatment success should go beyond reducing migraine frequency and focus on achieving near-total relief — an “ambitious but achievable” goal.
